Yasser Mostafa Hafez

594 total citations
28 papers, 431 citations indexed

About

Yasser Mostafa Hafez is a scholar working on Molecular Biology, Epidemiology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Yasser Mostafa Hafez has authored 28 papers receiving a total of 431 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Epidemiology and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Yasser Mostafa Hafez's work include Inflammasome and immune disorders (5 papers), Liver Disease Diagnosis and Treatment (4 papers) and Diabetic Foot Ulcer Assessment and Management (3 papers). Yasser Mostafa Hafez is often cited by papers focused on Inflammasome and immune disorders (5 papers), Liver Disease Diagnosis and Treatment (4 papers) and Diabetic Foot Ulcer Assessment and Management (3 papers). Yasser Mostafa Hafez collaborates with scholars based in Egypt, Saudi Arabia and Jordan. Yasser Mostafa Hafez's co-authors include Marwa Mohamed Atef, Marwa Nagy Emam, Rehab E. Abo El Gheit, Mohamed Khalfallah, Hemat El‐Sayed El‐Horany, Muhammad Tarek Abdel Ghafar, Hanan AlSaeid Alshenawy, Noha M. Shafik, Nema A. Soliman and Eman Basha and has published in prestigious journals such as International Journal of Molecular Sciences, Archives of Biochemistry and Biophysics and Journal of Cellular Biochemistry.

In The Last Decade

Yasser Mostafa Hafez

27 papers receiving 425 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yasser Mostafa Hafez Egypt 13 164 88 68 58 53 28 431
Chi Chen China 9 81 0.5× 64 0.7× 70 1.0× 83 1.4× 76 1.4× 20 421
Dongling Luo China 12 109 0.7× 40 0.5× 139 2.0× 57 1.0× 60 1.1× 33 496
Rong Luo China 11 98 0.6× 93 1.1× 68 1.0× 30 0.5× 83 1.6× 24 458
Feixia Shen China 11 200 1.2× 79 0.9× 39 0.6× 47 0.8× 67 1.3× 18 415
Xianghai Zhao China 11 87 0.5× 78 0.9× 75 1.1× 45 0.8× 63 1.2× 34 322
Takahiro Yamaji Japan 13 107 0.7× 131 1.5× 81 1.2× 40 0.7× 52 1.0× 28 520
Huaqin Wu China 12 150 0.9× 30 0.3× 127 1.9× 36 0.6× 55 1.0× 34 412
Cheng Ho Taiwan 15 236 1.4× 71 0.8× 27 0.4× 46 0.8× 47 0.9× 26 526
Shintaro Minegishi Japan 15 134 0.8× 78 0.9× 205 3.0× 66 1.1× 51 1.0× 38 516

Countries citing papers authored by Yasser Mostafa Hafez

Since Specialization
Citations

This map shows the geographic impact of Yasser Mostafa Hafez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yasser Mostafa Hafez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yasser Mostafa Hafez more than expected).

Fields of papers citing papers by Yasser Mostafa Hafez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yasser Mostafa Hafez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yasser Mostafa Hafez. The network helps show where Yasser Mostafa Hafez may publish in the future.

Co-authorship network of co-authors of Yasser Mostafa Hafez

This figure shows the co-authorship network connecting the top 25 collaborators of Yasser Mostafa Hafez. A scholar is included among the top collaborators of Yasser Mostafa Hafez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yasser Mostafa Hafez. Yasser Mostafa Hafez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ibrahim, Sarah, et al.. (2024). Selenium protects against nesfatin‐1 modulation of the hypothalamic‐pituitary‐testicular axis during hypothyroidism in male rats. Physiological Reports. 12(2). e15923–e15923. 1 indexed citations
2.
Hafez, Yasser Mostafa, et al.. (2024). Synergistic effects of AgNPs and zileuton on PCOS via ferroptosis and inflammation mitigation. Redox Report. 30(1). 2445398–2445398. 1 indexed citations
3.
Hafez, Yasser Mostafa, et al.. (2024). Effect of empagliflozin in peripheral diabetic neuropathy of patients with type 2 diabetes mellitus. Medicina Clínica. 163(2). 53–61. 9 indexed citations
4.
Basha, Eman, Marwa Mohamed Atef, Mohamad Taha, et al.. (2024). Protective effects of Kaempferol on hepatic apoptosis via miR-26a-5p enhancement and regulation of TLR4/NF-κB and PKCδ in a rat model of nonalcoholic fatty liver. The Journal of Nutritional Biochemistry. 137. 109833–109833. 2 indexed citations
5.
Atef, Marwa Mohamed, et al.. (2023). The potential protective effect of liraglutide on valproic acid induced liver injury in rats: Targeting HMGB1/RAGE axis and RIPK3/MLKL mediated necroptosis. Cell Biochemistry and Function. 41(8). 1209–1219. 6 indexed citations
6.
El‐Horany, Hemat El‐Sayed, et al.. (2023). Empagliflozin Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Rats by Modulating Sesn2/AMPK/Nrf2 Signaling and Targeting Ferroptosis and Autophagy. International Journal of Molecular Sciences. 24(11). 9481–9481. 44 indexed citations
7.
Hafez, Yasser Mostafa, et al.. (2023). The role of miR-433-3p in vascular calcification in type 2 diabetic patients: targeting WNT/β-Catenin and RANKL/RANK/OPG signaling pathways. Molecular Biology Reports. 50(11). 9073–9083. 2 indexed citations
8.
9.
Rizk, Fatma H., et al.. (2023). Ulinastatin ameliorated streptozotocin-induced diabetic nephropathy: Potential effects via modulating the components of gut-kidney axis and restoring mitochondrial homeostasis. Pflügers Archiv - European Journal of Physiology. 475(10). 1161–1176. 7 indexed citations
10.
11.
Gheit, Rehab E. Abo El, Marwa Nagy Emam, Nema A. Soliman, et al.. (2022). Irisin improves adiposity and exercise tolerance in a rat model of postmenopausal obesity through enhancing adipo-myocyte thermogenesis. Journal of Physiology and Biochemistry. 78(4). 897–913. 14 indexed citations
12.
Soliman, Nema A., et al.. (2020). Cross talk between Hsp72, HMGB1 and RAGE/ERK1/2 signaling in the pathogenesis of bronchial asthma in obese patients. Molecular Biology Reports. 47(6). 4109–4116. 9 indexed citations
13.
14.
Khalfallah, Mohamed, et al.. (2019). Predictors of poorly developed coronary collateral circulation in patients with subclinical hypothyroidism suffered from chronic stable angina. Global Cardiology Science and Practice. 2019(2). e201910–e201910. 2 indexed citations
15.
Atef, Marwa Mohamed, et al.. (2019). Diacerein protects against glycerol-induced acute kidney injury: Modulating oxidative stress, inflammation, apoptosis and necroptosis. Chemico-Biological Interactions. 306. 47–53. 53 indexed citations
16.
Atef, Marwa Mohamed, et al.. (2019). Therapeutic potential of sodium selenite in letrozole induced polycystic ovary syndrome rat model: Targeting mitochondrial approach (selenium in PCOS). Archives of Biochemistry and Biophysics. 671. 245–254. 39 indexed citations
17.
Atef, Marwa Mohamed, et al.. (2019). Targeting ERK/COX-2 signaling pathway in permethrin-induced testicular toxicity: a possible modulating effect of matrine. Molecular Biology Reports. 47(1). 247–259. 15 indexed citations
18.
19.
Hafez, Yasser Mostafa, et al.. (2018). The emerging role of the epigenetic enzyme Sirtuin-1 and high mobility group Box 1 in patients with diabetic foot ulceration. Diabetes & Metabolic Syndrome Clinical Research & Reviews. 12(6). 1065–1070. 13 indexed citations
20.
El‐Horany, Hemat El‐Sayed, et al.. (2017). NLRP3 expression and urinary HSP72 in relation to biomarkers of inflammation and oxidative stress in diabetic nephropathy patients. IUBMB Life. 69(8). 623–630. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chi Chen Breakdown of academic impact, for papers by Dongling Luo Breakdown of academic impact, for papers by Rong Luo Breakdown of academic impact, for papers by Feixia Shen Breakdown of academic impact, for papers by Xianghai Zhao Breakdown of academic impact, for papers by Takahiro Yamaji Breakdown of academic impact, for papers by Huaqin Wu Breakdown of academic impact, for papers by Cheng Ho Breakdown of academic impact, for papers by Shintaro Minegishi
Rankless by CCL
2026